nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.117	0.167	CbGbCtD
Neostigmine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.106	0.151	CbGbCtD
Neostigmine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0912	0.131	CbGbCtD
Neostigmine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0886	0.127	CbGbCtD
Neostigmine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0801	0.115	CbGbCtD
Neostigmine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0801	0.115	CbGbCtD
Neostigmine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0768	0.11	CbGbCtD
Neostigmine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0594	0.085	CbGbCtD
Neostigmine—BCHE—blood plasma—acquired immunodeficiency syndrome	0.00116	0.115	CbGeAlD
Neostigmine—ACHE—spinal cord—acquired immunodeficiency syndrome	0.000834	0.0827	CbGeAlD
Neostigmine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000637	0.00219	CcSEcCtD
Neostigmine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000634	0.00218	CcSEcCtD
Neostigmine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000632	0.00217	CcSEcCtD
Neostigmine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00063	0.00216	CcSEcCtD
Neostigmine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000628	0.00216	CcSEcCtD
Neostigmine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000628	0.00216	CcSEcCtD
Neostigmine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000627	0.00215	CcSEcCtD
Neostigmine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000623	0.00214	CcSEcCtD
Neostigmine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000623	0.00214	CcSEcCtD
Neostigmine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000623	0.00214	CcSEcCtD
Neostigmine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000623	0.00214	CcSEcCtD
Neostigmine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000623	0.00214	CcSEcCtD
Neostigmine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000622	0.00214	CcSEcCtD
Neostigmine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000621	0.00213	CcSEcCtD
Neostigmine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00062	0.00213	CcSEcCtD
Neostigmine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00062	0.00213	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000619	0.00213	CcSEcCtD
Neostigmine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000619	0.00213	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000619	0.00212	CcSEcCtD
Neostigmine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000618	0.00212	CcSEcCtD
Neostigmine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000616	0.00212	CcSEcCtD
Neostigmine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000616	0.00211	CcSEcCtD
Neostigmine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000616	0.00211	CcSEcCtD
Neostigmine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000615	0.00211	CcSEcCtD
Neostigmine—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000614	0.00211	CcSEcCtD
Neostigmine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000614	0.00211	CcSEcCtD
Neostigmine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000612	0.0021	CcSEcCtD
Neostigmine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000611	0.0021	CcSEcCtD
Neostigmine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000609	0.00209	CcSEcCtD
Neostigmine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000609	0.00209	CcSEcCtD
Neostigmine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000606	0.00208	CcSEcCtD
Neostigmine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000604	0.00208	CcSEcCtD
Neostigmine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000599	0.00206	CcSEcCtD
Neostigmine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000597	0.00205	CcSEcCtD
Neostigmine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000596	0.00205	CcSEcCtD
Neostigmine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000595	0.00204	CcSEcCtD
Neostigmine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000588	0.00202	CcSEcCtD
Neostigmine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000587	0.00202	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000587	0.00202	CcSEcCtD
Neostigmine—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000586	0.00201	CcSEcCtD
Neostigmine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000586	0.00201	CcSEcCtD
Neostigmine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000583	0.002	CcSEcCtD
Neostigmine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000583	0.002	CcSEcCtD
Neostigmine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000581	0.002	CcSEcCtD
Neostigmine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000581	0.00199	CcSEcCtD
Neostigmine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00058	0.00199	CcSEcCtD
Neostigmine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000578	0.00198	CcSEcCtD
Neostigmine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000578	0.00198	CcSEcCtD
Neostigmine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000576	0.00198	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000576	0.00198	CcSEcCtD
Neostigmine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000573	0.00197	CcSEcCtD
Neostigmine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000573	0.00197	CcSEcCtD
Neostigmine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000573	0.00197	CcSEcCtD
Neostigmine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000572	0.00196	CcSEcCtD
Neostigmine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000572	0.00196	CcSEcCtD
Neostigmine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000569	0.00195	CcSEcCtD
Neostigmine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000568	0.00195	CcSEcCtD
Neostigmine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000568	0.00195	CcSEcCtD
Neostigmine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000568	0.00195	CcSEcCtD
Neostigmine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000564	0.00194	CcSEcCtD
Neostigmine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000564	0.00194	CcSEcCtD
Neostigmine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000563	0.00193	CcSEcCtD
Neostigmine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000562	0.00193	CcSEcCtD
Neostigmine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000562	0.00193	CcSEcCtD
Neostigmine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000561	0.00193	CcSEcCtD
Neostigmine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000561	0.00193	CcSEcCtD
Neostigmine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000559	0.00192	CcSEcCtD
Neostigmine—BCHE—skin of body—acquired immunodeficiency syndrome	0.000558	0.0554	CbGeAlD
Neostigmine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000558	0.00192	CcSEcCtD
Neostigmine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000556	0.00191	CcSEcCtD
Neostigmine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000555	0.00191	CcSEcCtD
Neostigmine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000555	0.00191	CcSEcCtD
Neostigmine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000554	0.0019	CcSEcCtD
Neostigmine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000553	0.0019	CcSEcCtD
Neostigmine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000553	0.0549	CbGeAlD
Neostigmine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000553	0.0019	CcSEcCtD
Neostigmine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000553	0.0019	CcSEcCtD
Neostigmine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000551	0.00189	CcSEcCtD
Neostigmine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000548	0.00188	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000548	0.00188	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000546	0.00187	CcSEcCtD
Neostigmine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000545	0.00187	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000544	0.00187	CcSEcCtD
Neostigmine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00054	0.00186	CcSEcCtD
Neostigmine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00054	0.00185	CcSEcCtD
Neostigmine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00054	0.00185	CcSEcCtD
Neostigmine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000539	0.00185	CcSEcCtD
Neostigmine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000537	0.00185	CcSEcCtD
Neostigmine—ACHE—brain—acquired immunodeficiency syndrome	0.000537	0.0533	CbGeAlD
Neostigmine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000537	0.00184	CcSEcCtD
Neostigmine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000535	0.00184	CcSEcCtD
Neostigmine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000535	0.00184	CcSEcCtD
Neostigmine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000534	0.00183	CcSEcCtD
Neostigmine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000533	0.00183	CcSEcCtD
Neostigmine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000533	0.00183	CcSEcCtD
Neostigmine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000531	0.00182	CcSEcCtD
Neostigmine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000531	0.00182	CcSEcCtD
Neostigmine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000527	0.00181	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000527	0.00181	CcSEcCtD
Neostigmine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000523	0.00179	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000521	0.00179	CcSEcCtD
Neostigmine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00052	0.00179	CcSEcCtD
Neostigmine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000519	0.00178	CcSEcCtD
Neostigmine—ACHE—lymph node—acquired immunodeficiency syndrome	0.000519	0.0515	CbGeAlD
Neostigmine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000519	0.00178	CcSEcCtD
Neostigmine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000518	0.00178	CcSEcCtD
Neostigmine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000517	0.00178	CcSEcCtD
Neostigmine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000517	0.00178	CcSEcCtD
Neostigmine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000517	0.00178	CcSEcCtD
Neostigmine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000516	0.00177	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000516	0.00177	CcSEcCtD
Neostigmine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000515	0.00177	CcSEcCtD
Neostigmine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000515	0.00177	CcSEcCtD
Neostigmine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000513	0.00176	CcSEcCtD
Neostigmine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000511	0.00175	CcSEcCtD
Neostigmine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000511	0.00175	CcSEcCtD
Neostigmine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00051	0.00175	CcSEcCtD
Neostigmine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00051	0.00175	CcSEcCtD
Neostigmine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00051	0.00175	CcSEcCtD
Neostigmine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000508	0.00174	CcSEcCtD
Neostigmine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000508	0.00174	CcSEcCtD
Neostigmine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000506	0.00174	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000503	0.00173	CcSEcCtD
Neostigmine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000502	0.00172	CcSEcCtD
Neostigmine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000501	0.00172	CcSEcCtD
Neostigmine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.0005	0.00172	CcSEcCtD
Neostigmine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000499	0.00171	CcSEcCtD
Neostigmine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000499	0.00171	CcSEcCtD
Neostigmine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000497	0.00171	CcSEcCtD
Neostigmine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000495	0.0017	CcSEcCtD
Neostigmine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000495	0.0017	CcSEcCtD
Neostigmine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000494	0.0017	CcSEcCtD
Neostigmine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000494	0.0017	CcSEcCtD
Neostigmine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000494	0.0017	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000493	0.00169	CcSEcCtD
Neostigmine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000493	0.00169	CcSEcCtD
Neostigmine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000493	0.00169	CcSEcCtD
Neostigmine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000492	0.00169	CcSEcCtD
Neostigmine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000492	0.00169	CcSEcCtD
Neostigmine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00049	0.00168	CcSEcCtD
Neostigmine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00049	0.00168	CcSEcCtD
Neostigmine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000489	0.00168	CcSEcCtD
Neostigmine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000488	0.00167	CcSEcCtD
Neostigmine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000486	0.00167	CcSEcCtD
Neostigmine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000485	0.00167	CcSEcCtD
Neostigmine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.00167	CcSEcCtD
Neostigmine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000483	0.00166	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000482	0.00165	CcSEcCtD
Neostigmine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000481	0.00165	CcSEcCtD
Neostigmine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000481	0.00165	CcSEcCtD
Neostigmine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000478	0.00164	CcSEcCtD
Neostigmine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000478	0.00164	CcSEcCtD
Neostigmine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000476	0.00163	CcSEcCtD
Neostigmine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000475	0.00163	CcSEcCtD
Neostigmine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.00163	CcSEcCtD
Neostigmine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000472	0.00162	CcSEcCtD
Neostigmine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000471	0.00162	CcSEcCtD
Neostigmine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000471	0.00162	CcSEcCtD
Neostigmine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00047	0.00161	CcSEcCtD
Neostigmine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000469	0.00161	CcSEcCtD
Neostigmine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000467	0.0016	CcSEcCtD
Neostigmine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000466	0.0016	CcSEcCtD
Neostigmine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000466	0.0016	CcSEcCtD
Neostigmine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000465	0.0016	CcSEcCtD
Neostigmine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000465	0.0016	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000464	0.00159	CcSEcCtD
Neostigmine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00046	0.00158	CcSEcCtD
Neostigmine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000458	0.00157	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000456	0.00157	CcSEcCtD
Neostigmine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000454	0.00156	CcSEcCtD
Neostigmine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000454	0.00156	CcSEcCtD
Neostigmine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000454	0.00156	CcSEcCtD
Neostigmine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000454	0.00156	CcSEcCtD
Neostigmine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000452	0.00155	CcSEcCtD
Neostigmine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000452	0.00155	CcSEcCtD
Neostigmine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00045	0.00154	CcSEcCtD
Neostigmine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000447	0.00154	CcSEcCtD
Neostigmine—BCHE—digestive system—acquired immunodeficiency syndrome	0.000446	0.0443	CbGeAlD
Neostigmine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000442	0.00152	CcSEcCtD
Neostigmine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00044	0.00151	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000439	0.00151	CcSEcCtD
Neostigmine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000439	0.00151	CcSEcCtD
Neostigmine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000433	0.00149	CcSEcCtD
Neostigmine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000433	0.00149	CcSEcCtD
Neostigmine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000432	0.00148	CcSEcCtD
Neostigmine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000432	0.00148	CcSEcCtD
Neostigmine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000431	0.00148	CcSEcCtD
Neostigmine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000429	0.00147	CcSEcCtD
Neostigmine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000429	0.00147	CcSEcCtD
Neostigmine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000428	0.00147	CcSEcCtD
Neostigmine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000426	0.00146	CcSEcCtD
Neostigmine—BCHE—blood—acquired immunodeficiency syndrome	0.000425	0.0422	CbGeAlD
Neostigmine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000423	0.00145	CcSEcCtD
Neostigmine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000421	0.00145	CcSEcCtD
Neostigmine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.00144	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000419	0.00144	CcSEcCtD
Neostigmine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000418	0.00144	CcSEcCtD
Neostigmine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000418	0.00143	CcSEcCtD
Neostigmine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000416	0.00143	CcSEcCtD
Neostigmine—BCHE—bone marrow—acquired immunodeficiency syndrome	0.000412	0.0408	CbGeAlD
Neostigmine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00041	0.00141	CcSEcCtD
Neostigmine—BCHE—spinal cord—acquired immunodeficiency syndrome	0.00041	0.0407	CbGeAlD
Neostigmine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000409	0.0014	CcSEcCtD
Neostigmine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000404	0.00139	CcSEcCtD
Neostigmine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000404	0.00139	CcSEcCtD
Neostigmine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000404	0.00139	CcSEcCtD
Neostigmine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000402	0.00138	CcSEcCtD
Neostigmine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000402	0.00138	CcSEcCtD
Neostigmine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000399	0.00137	CcSEcCtD
Neostigmine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000398	0.00137	CcSEcCtD
Neostigmine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000397	0.00136	CcSEcCtD
Neostigmine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000396	0.00136	CcSEcCtD
Neostigmine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000395	0.00136	CcSEcCtD
Neostigmine—BCHE—vagina—acquired immunodeficiency syndrome	0.000394	0.0391	CbGeAlD
Neostigmine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.00134	CcSEcCtD
Neostigmine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000389	0.00134	CcSEcCtD
Neostigmine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.00132	CcSEcCtD
Neostigmine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000384	0.00132	CcSEcCtD
Neostigmine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00038	0.0013	CcSEcCtD
Neostigmine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000379	0.0013	CcSEcCtD
Neostigmine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.0013	CcSEcCtD
Neostigmine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000377	0.00129	CcSEcCtD
Neostigmine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000376	0.00129	CcSEcCtD
Neostigmine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000376	0.00129	CcSEcCtD
Neostigmine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000375	0.00129	CcSEcCtD
Neostigmine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000374	0.00128	CcSEcCtD
Neostigmine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000374	0.00128	CcSEcCtD
Neostigmine—BCHE—lung—acquired immunodeficiency syndrome	0.000373	0.037	CbGeAlD
Neostigmine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.00125	CcSEcCtD
Neostigmine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000363	0.00125	CcSEcCtD
Neostigmine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000362	0.00124	CcSEcCtD
Neostigmine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.00124	CcSEcCtD
Neostigmine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.00124	CcSEcCtD
Neostigmine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.00124	CcSEcCtD
Neostigmine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00123	CcSEcCtD
Neostigmine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000358	0.00123	CcSEcCtD
Neostigmine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00122	CcSEcCtD
Neostigmine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.0012	CcSEcCtD
Neostigmine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000348	0.0012	CcSEcCtD
Neostigmine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.0012	CcSEcCtD
Neostigmine—BCHE—nervous system—acquired immunodeficiency syndrome	0.000345	0.0343	CbGeAlD
Neostigmine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.00118	CcSEcCtD
Neostigmine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00117	CcSEcCtD
Neostigmine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.00116	CcSEcCtD
Neostigmine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.00115	CcSEcCtD
Neostigmine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.00114	CcSEcCtD
Neostigmine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.00114	CcSEcCtD
Neostigmine—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000332	0.033	CbGeAlD
Neostigmine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.00114	CcSEcCtD
Neostigmine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.00114	CcSEcCtD
Neostigmine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000323	0.00111	CcSEcCtD
Neostigmine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.0011	CcSEcCtD
Neostigmine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.0011	CcSEcCtD
Neostigmine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.0011	CcSEcCtD
Neostigmine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000319	0.00109	CcSEcCtD
Neostigmine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00108	CcSEcCtD
Neostigmine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.00106	CcSEcCtD
Neostigmine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.00105	CcSEcCtD
Neostigmine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.00105	CcSEcCtD
Neostigmine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.00104	CcSEcCtD
Neostigmine—ABCB1—retina—acquired immunodeficiency syndrome	0.000303	0.0301	CbGeAlD
Neostigmine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00104	CcSEcCtD
Neostigmine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.00099	CcSEcCtD
Neostigmine—BCHE—brain—acquired immunodeficiency syndrome	0.000264	0.0262	CbGeAlD
Neostigmine—BCHE—lymph node—acquired immunodeficiency syndrome	0.000255	0.0253	CbGeAlD
Neostigmine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000215	0.0214	CbGeAlD
Neostigmine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000213	0.0211	CbGeAlD
Neostigmine—ABCB1—blood—acquired immunodeficiency syndrome	0.000203	0.0201	CbGeAlD
Neostigmine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000196	0.0195	CbGeAlD
Neostigmine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000195	0.0194	CbGeAlD
Neostigmine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000188	0.0186	CbGeAlD
Neostigmine—ABCB1—lung—acquired immunodeficiency syndrome	0.000178	0.0176	CbGeAlD
Neostigmine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000165	0.0163	CbGeAlD
Neostigmine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000158	0.0157	CbGeAlD
Neostigmine—ABCB1—brain—acquired immunodeficiency syndrome	0.000126	0.0125	CbGeAlD
Neostigmine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000122	0.0121	CbGeAlD
